Notice of Preliminary Year End Results
Abingdon Health plc (AIM: ABDX) a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, will announce its preliminary results for the year ended 30 June 2025 on Tuesday 11 November 2025.
Investor Presentation
The Company will provide a live presentation relating to the preliminary results via the Investor Meet Company platform on Tuesday 11 November 2025 at 11:00 GMT.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 09:00 GMT the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Abingdon Health plc via:
https://www.investormeetcompany.com/abingdon-health-plc/register-investor
Investors who already follow Abingdon Health plc on the Investor Meet Company platform will automatically be invited.
Result of General Meeting and Total Voting Rights
Abingdon Health plc is also pleased to announce that, at the General Meeting held on Thursday 30 October 2025, the Resolutions set out in the Notice of General Meeting contained in the Circular dated 14 October 2025 were duly passed. Read the full update here: https://www.abingdonhealth.com/investors/regulatory-announcements/
